Buprenex (buprenorphine) / Reckitt Benckiser 
Welcome,         Profile    Billing    Logout  
 15 Diseases   2 Trials   2 Trials   89 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Buprenex (buprenorphine) / Reckitt Benckiser
NCT02187198: Buprenorphine Treatment for Opioid Dependence

Completed
3
9
US
Buprenorphine, Naloxone, Suboxone, Buprenex, Subutex
Yale University, United States Department of Defense
Opioid Dependence
02/22
01/23
NCT03852628: Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

Terminated
2
69
US
2mg Buprenex and 380mg Vivitrol, 2mg Buprenex (SL, qd) and 380mg Vivitrol (IM, q4weeks), 2mg BUP/NLTRX, Placebo (SL pill qd, IM injection q4weeks), Placebo
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance, United States Department of Defense, RTI International
Post Traumatic Stress Disorder, Alcohol Abuse
05/22
01/23
NCT04752384: Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients

Active, not recruiting
2
20
US
Buprenorphine, Belbuca, Probuphine, Buprenex, Tramadol, Ultram, Ryzolt, ConZip, Oral Mucositis (OM) Pain App, OM Pain App
Medical College of Wisconsin
Head and Neck Squamous Cell Carcinoma
04/24
09/25
NCT03460314: Bariatric Surgery and Pharmacokinetics of Buprenorphine

Recruiting
N/A
12
Europe
Buprenorphine, Buprenorphine hydrochloride, Buprenex
Norwegian University of Science and Technology, St. Olavs Hospital, Volvat Medisinsk Senter Stokkan, Namsos Hospital, Alesund Hospital
Obesity, Morbid
10/26
10/26

Download Options